Chimeric Therapeutics is trading 5.6% up at A$0.04 as the stock rebounds from recent selling pressure.

  • The move is being attributed to bargain hunting after a pullback from around A$0.05 in prior sessions.
  • There are no fresh company-specific news or announcements driving the move, with broader biotech sector strength providing a supportive backdrop.